My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 359

    1.

    Quantitative evaluation of the corneal endothelium in the mouse after grafting.

    Plskova J, Kuffova L, Filipec M, Holan V, Forrester JV.

    Br J Ophthalmol. 2004 Sep;88(9):1209-16.PMID: 15317718 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Lymph node removal enhances corneal graft survival in mice at high risk of rejection.

    Plsková J, Holán V, Filipec M, Forrester JV.

    BMC Ophthalmol. 2004 Mar 23;4:3.PMID: 15038832 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Ex vivo adenovirus-mediated gene transfer to corneal graft endothelial cells in mice.

    Qian Y, Leong FL, Kazlauskas A, Dana MR.

    Invest Ophthalmol Vis Sci. 2004 Jul;45(7):2187-93.PMID: 15223794 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Corneal graft rejection is accompanied by apoptosis of the endothelium and is prevented by gene therapy with bcl-xL.

    Barcia RN, Dana MR, Kazlauskas A.

    Am J Transplant. 2007 Sep;7(9):2082-9. Epub 2007 Jul 5.PMID: 17614980 [PubMed - indexed for MEDLINE]Related articles

    5.

    CD95 ligand expression on corneal epithelium and endothelium influences the fates of orthotopic and heterotopic corneal allografts in mice.

    Osawa H, Maruyama K, Streilein JW.

    Invest Ophthalmol Vis Sci. 2004 Jun;45(6):1908-15.PMID: 15161857 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Dynamics of donor cell persistence and recipient cell replacement in orthotopic corneal allografts in mice.

    Hori J, Streilein JW.

    Invest Ophthalmol Vis Sci. 2001 Jul;42(8):1820-8.PMID: 11431448 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Evaluation of corneal graft rejection in a mouse model.

    Plsková J, Kuffová L, Holán V, Filipec M, Forrester JV.

    Br J Ophthalmol. 2002 Jan;86(1):108-13.PMID: 11801514 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Epithelium-deficient corneal allografts display immune privilege beneath the kidney capsule.

    Hori J, Joyce N, Streilein JW.

    Invest Ophthalmol Vis Sci. 2000 Feb;41(2):443-52.PMID: 10670474 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    A mouse model of allogeneic corneal endothelial cell transplantation.

    Hayashi T, Yamagami S, Tanaka K, Yokoo S, Usui T, Amano S, Mizuki N.

    Cornea. 2008 Jul;27(6):699-705.PMID: 18580263 [PubMed - indexed for MEDLINE]Related articles

    10.

    Immune privilege and immunogenicity reside among different layers of the mouse cornea.

    Hori J, Joyce NC, Streilein JW.

    Invest Ophthalmol Vis Sci. 2000 Sep;41(10):3032-42.PMID: 10967061 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Survival in high-risk eyes of epithelium-deprived orthotopic corneal allografts reconstituted in vitro with syngeneic epithelium.

    Hori J, Streilein JW.

    Invest Ophthalmol Vis Sci. 2003 Feb;44(2):658-64.PMID: 12556396 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice.

    Hori J, Streilein JW.

    Invest Ophthalmol Vis Sci. 2001 Mar;42(3):720-6.PMID: 11222533 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Orthotopic corneal transplantation in mice--evidence that the immunogenetic rules of rejection do not apply.

    Sonoda Y, Streilein JW.

    Transplantation. 1992 Oct;54(4):694-704.PMID: 1412761 [PubMed - indexed for MEDLINE]Related articles

    14.

    FK 506 and aminoguanidine suppress iNOS induction in orthotopic corneal allografts and prolong graft survival in mice.

    Strestíková P, Plsková J, Filipec M, Farghali H.

    Nitric Oxide. 2003 Sep;9(2):111-7.PMID: 14623177 [PubMed - indexed for MEDLINE]Related articles

    15.

    Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival.

    Cursiefen C, Cao J, Chen L, Liu Y, Maruyama K, Jackson D, Kruse FE, Wiegand SJ, Dana MR, Streilein JW.

    Invest Ophthalmol Vis Sci. 2004 Aug;45(8):2666-73.PMID: 15277490 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Corneal allograft endothelial cell replacement represents a reparative response to transplant injury.

    Gong N, Pleyer U, Ritter T, Knop E, Chen X.

    Mol Vis. 2009;15:654-61. Epub 2009 Apr 3.PMID: 19347050 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Blockade of the 4-1BB (CD137)/4-1BBL and/or CD28/CD80/CD86 costimulatory pathways promotes corneal allograft survival in mice.

    Asai T, Choi BK, Kwon PM, Kim WY, Kim JD, Vinay DS, Gebhardt BM, Kwon BS.

    Immunology. 2007 Jul;121(3):349-58. Epub 2007 Mar 22.PMID: 17376197 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Orthotopic corneal transplantation in the mouse--a new surgical technique with minimal endothelial cell loss.

    Zhang EP, Schründer S, Hoffmann F.

    Graefes Arch Clin Exp Ophthalmol. 1996 Nov;234(11):714-9.PMID: 8950593 [PubMed - indexed for MEDLINE]Related articles

    19.

    A murine model of interlamellar corneal transplantation.

    Lau CH, Nicholls SM, Easty DL.

    Br J Ophthalmol. 1998 Mar;82(3):294-9.PMID: 9602628 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation.

    Bachmann BO, Bock F, Wiegand SJ, Maruyama K, Dana MR, Kruse FE, Luetjen-Drecoll E, Cursiefen C.

    Arch Ophthalmol. 2008 Jan;126(1):71-7.PMID: 18195221 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity